New transplant method aims to cut dangerous side effects in blood cancer patients

This study tests a special way to process donated stem cells to make transplants safer for people with leukemia or lymphoma. The goal is to reduce serious complications like graft-versus-host disease, where donor cells attack the patient's body. About 100 participants will receive a stem cell transplant using the CliniMACS system, which enriches healthy stem cells and removes immune cells that can cause harm. Researchers will track survival, disease relapse, and side effects to see if this approach improves outcomes.